Dean Arthur Rubenstein of the Perelman School of Medicine is featured as he prepares to retire as dean.
Perelman School of Medicine
Arthur Caplan of the Perelman School of Medicine shares his opinion on patients leaving their inheritance to their health-care providers.
Joseph Carver of the Perelman School of Medicine comments on doctors’ increased focus on the long-term effects of cancer treatment.
Next Generation Gene Therapy: Penn Study Shows Potential of Gene Vector to Broaden Eye-Disease Treatment
Philadelphia — Inspired by earlier successes using gene therapy to correct an inherited type of blindness, investigators from the Perelman School of Medicine at the University of Pennsylvania, are poised to extend their approach to other types of blinding disorders.
Philadelphia — There are new genetic clues on risk factors and biological causes of a rare neurodegenerative disease called progressive supranuclear palsy (PSP), according to a new study from an international genetics team led by researchers from the Perelman School of Medicine at the University of Pennsylvania. In the largest genetics study of the disease, three new genes associated with risk for PSP were identified and two additional genetic variants affecting risk for PSP were confirmed.
Jeffrey Weiser and post-doctoral research Thomas Clarke of the Perelman School of Medicine are cited for their research on microbes.
Michael Cirigliano of the Perelman School of Medicine comments on digesting too much vitamin A.
Joseph Sobanko of the Perelman School of Medicine discusses why higher SPFs are not more effective than others.